Treatment of Visual Disorders in Parkinson Disease

被引:10
作者
Savitt, Joseph [1 ]
Mathews, Michaela [2 ]
机构
[1] Univ Maryland, Sch Med, Dept Neurol, 110 South Paca St 3rd Floor, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Ophthalmol, Baltimore, MD 21201 USA
关键词
Parkinson disease; Visual dysfunction; Treatment; Ocular; Parkinsonism; Therapy; PROGRESSIVE SUPRANUCLEAR PALSY; DEEP BRAIN-STIMULATION; CONTRAST SENSITIVITY; DOWNBEAT NYSTAGMUS; BOTULINUM TOXIN; OCULAR MOTOR; L-DOPA; HALLUCINATIONS; SYMPTOMS; APRAXIA;
D O I
10.1007/s11940-018-0519-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This article discusses visual disorders in both Parkinson disease (PD) and other Parkinsonian disorders. It is organized largely by the anatomical site of pathology and emphasizes practical treatments. Targeted treatment options include medications, surgery, occupational, and physical therapies as well as optical aids. The causes of visual complaints in Parkinson disease and other similar disorders are being more clearly identified. A new medication approved specifically to treat hallucinations in PD now is available. There is increased understanding of the important role that an ophthalmologist can play in the care of these patients. Finally, research and therapeutic development are unmet needs in accessing and treating visual complaints in PD and Parkinsonian disorders. A better understanding of Parkinson-related visual complaints and of available treatment options is important to optimize patient safety and quality of life. Vision impairment leads to difficulties in many common activities including reading, ambulating, and driving. Falls and injuries, made more likely because of impaired vision, result in an early loss of independence. Awareness of the problem, patient education, ophthalmologic care, selected therapeutics, physical therapy, and occupational therapy are crucial to maximizing quality of life in these patients.
引用
收藏
页数:15
相关论文
共 92 条
  • [1] Ocular Motor and Sensory Function in Parkinson's Disease
    Almer, Zina
    Klein, Kathyrn S.
    Marsh, Laura
    Gerstenhaber, Melissa
    Repka, Michael X.
    [J]. OPHTHALMOLOGY, 2012, 119 (01) : 178 - 182
  • [2] Antal A, 1998, CLIN NEUROSCI, V5, P147
  • [3] PRETARSAL APPLICATION OF BOTULINUM TOXIN FOR TREATMENT OF BLEPHAROSPASM
    ARAMIDEH, M
    DEVISSER, BWO
    BRANS, JWM
    KOELMAN, JHTM
    SPEELMAN, JD
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 59 (03) : 309 - 311
  • [4] Visual symptoms in Parkinson's disease and Parkinson's disease dementia
    Archibald, Neil K.
    Clarke, Mike P.
    Mosimann, Urs P.
    Burn, David J.
    [J]. MOVEMENT DISORDERS, 2011, 26 (13) : 2387 - 2395
  • [5] Armstrong RA, 2017, INT REV NEUROBIOL, V134, P921, DOI [10.1016/bs.im.2017.04.007, 10.1016/bs.irn.2017.04.007]
  • [6] Visual signs and symptoms of corticobasal degeneration
    Armstrong, Richard A.
    [J]. CLINICAL AND EXPERIMENTAL OPTOMETRY, 2016, 99 (06) : 498 - 506
  • [7] Visual signs and symptoms of multiple system atrophy
    Armstrong, Richard A.
    [J]. CLINICAL AND EXPERIMENTAL OPTOMETRY, 2014, 97 (06) : 483 - 491
  • [8] Visual System Involvement in Patients with Newly Diagnosed Parkinson Disease
    Arrigo, Alessandro
    Calamuneri, Alessandro
    Milardi, Demetrio
    Mormina, Enricomaria
    Rania, Laura
    Postorino, Elisa
    Marino, Silvia
    Di Lorenzo, Giuseppe
    Anastasi, Giuseppe Pio
    Ghilardi, Maria Felice
    Aragona, Pasquale
    Quartarone, Angelo
    Gaeta, Michele
    [J]. RADIOLOGY, 2017, 285 (03) : 885 - 895
  • [9] The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients
    Bares, M
    Brázdil, M
    Kanovsky, P
    Jurák, P
    Daniel, P
    Kukleta, M
    Rektor, I
    [J]. PARKINSONISM & RELATED DISORDERS, 2003, 9 (03) : 139 - 144
  • [10] A critical evaluation of the evidence supporting the practice of behavioural vision therapy
    Barrett, Brendan T.
    [J]. OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2009, 29 (01) : 4 - 25